Gerlinde Averous

Dr. Gerlinde Averous

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2017 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SVS. Valmary-Degano
S. Valmary-Degano
PCP. Colpart
P. Colpart
LVLAURENT VILLENEUVE
LAURENT VILLENEUVE
FMFranck Monnien
Franck Monnien
LML. M'Hamdi
L. M'Hamdi
FZF. Zinzindohoue
F. Zinzindohoue

1 March 2016 in Journal of Virological Methods
Verified
Journal Article
Closed access
HBHeidi Barth
Heidi Barth
AMAdrien Morel
Adrien Morel
CMChristiane Mougin
Christiane Mougin
GAGerlinde Averous
Gerlinde Averous
MLMichèle Legrain
Michèle Legrain
FSFrançoise Stoll-Keller
Françoise Stoll-Keller

20 February 2025 in American Journal of Surgical Pathology
Verified
Journal Article
Open access
PDPeggy Dartigues
Peggy Dartigues
VKVahan Képénékian
Vahan Képénékian
CIClaire Illac-Vauquelin
Claire Illac-Vauquelin
VVVéronique Verriele
Véronique Verriele
JFJuliette Fontaine
Juliette Fontaine
ONOn Behalf Of The Renape Network
On Behalf Of The Renape Network
High-grade appendiceal mucinous neoplasm (HAMN) is used to describe a rare epithelial neoplasm of the appendix characterized by pushing-type invasion and high-grade cytologic atypia. Its implications regarding lymph node spread and the necessity of right colectomy are currently debate. The objective of the present study was to assess the clinicopathologic characteristics, the risk of lymph node and peritoneal metastasis, and long-term outcomes of patients diagnosed as HAMN in comparison to low-grade appendiceal mucinous neoplasm (LAMN) and appendiceal adenocarcinoma, treated by right hemicolectomy. A total of 443 patients diagnosed with LAMN (n=246), HAMN (n=34), or appendiceal adenocarcinoma (n=163) and who underwent right colectomy with lymph node dissection in all cases within 32 institutions of the French Network for Rare Peritoneal Malignancies (RENAPE) were included. The median age was 56.5 years (range: 21 to 91), and the majority were female (n=250, 56.4%) without difference between groups (P=0.604). Lymph node metastases were identified in 17.8% of appendiceal adenocarcinoma cases (29/163); none were found among LAMN or HAMN cases. A higher number of lymph nodes were analyzed in those treated for appendiceal adenocarcinoma than LAMN (P<0.001) and HAMN (P=0.035). Regarding peritoneal metastasis, a higher proportion of cases were classified as high-grade with/without signet cells in patients treated for HAMN (P<0.001) and appendiceal adenocarcinoma (P<0.001) than those treated for LAMN. Among patients with perforation of the appendix, those treated for LAMN had longer overall survival (OS; P<0.001) and progression-free survival (PFS; P<0.0001) than those treated for appendiceal adenocarcinoma or those treated for HAMN; among patients without perforation, those treated for LAMN and HAMN had longer OS (P=0.042) and PFS (P=0.012) than those treated for appendiceal adenocarcinoma. No lymph node metastases were observed in patients treated for HAMN, and those without appendix perforation had a similar prognosis to LAMN. This study supports staging HAMN using the same system as LAMN and treating it with appendectomy alone in the absence of appendix perforation.

1 August 2021 in HPB
Verified
Journal Article
Closed access
PAPietro Addeo
Pietro Addeo
AFAntonin Fattori
Antonin Fattori
CGCaroline Grunder
Caroline Grunder
PDPatrick Dufour
Patrick Dufour
GAGerlinde Averous
Gerlinde Averous
PBPhilippe Bachellier
Philippe Bachellier

1 July 2019 in Digestive and Liver Disease
Verified
Journal Article
Closed access
PAPietro Addeo
Pietro Addeo
GAGerlinde Averous
Gerlinde Averous
PBPhilippe Bachellier
Philippe Bachellier

8 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SASamuel Aymard
Samuel Aymard
BLBenjamin Leroy-Freschini
Benjamin Leroy-Freschini
AKAshjan Kaseb
Ashjan Kaseb
DMDavid Marx
David Marx
MHMehdi Helali
Mehdi Helali
AIAlessio Imperiale
Alessio Imperiale
Hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) includes secondary (sHPT) and tertiary hyperparathyroidism (tHPT). Considering that the role of preoperative imaging in the clinical setting is controversial, in the present study we have retrospectively compared pre-surgical diagnostic performances of 18F-Fluorocholine (18F-FCH) PET/CT, cervical ultrasonography (US), parathyroid scintigraphy, and 4D-CT in a group of 30 patients with CKD and HPT (18/12 sHPT/tHPT), 21 CKD G5 including 18 in dialysis, and 9 kidney transplant recipients. All patients underwent 18F-FCH, and 22 had cervical US, 12 had parathyroid scintigraphy, and 11 had 4D-CT. Histopathology was the gold standard. Seventy-four parathyroids were removed: 65 hyperplasia, 6 adenomas, and 3 normal glands. In the whole population, in a per gland analysis, 18F-FCH PET/CT was significantly more sensitive and accurate (72%, 71%) than neck US (25%, 43%), parathyroid scintigraphy (35%, 47%), and 4D-CT (40%, 47%). The specificity of 18F-FCH PET/CT (69%) was lower than that of neck US (95%) and parathyroid scintigraphy (90%), without, however, achieving significance. 18F-FCH PET/CT was more accurate than all other diagnostic techniques when sHPT and tHPT patients were considered separately. 18F-FCH PET/CT sensitivity was significantly higher in tHPT (88%) than in sHPT (66%). Three ectopic hyperfunctioning glands (in three different patients) were all detected by 18F-FCH PET/CT, two by parathyroid scintigraphy, and none by cervical US and 4D-CT. Our study confirms that 18F-FCH PET/CT is an effective preoperative imaging option in patients with CKD and HPT. These findings may be of greater importance in patients with tHPT (who could benefit from minimally invasive parathyroidectomy) than in patients with sHPT, who often undergo bilateral cervicotomy. In these cases, preoperative 18F-FCH PET/CT may be helpful in locating ectopic glands and may guide the surgical choice for gland preservation.